Lumexa Imaging Holdings, Inc. Capital Expenditures Incurred but Not yet Paid
Lumexa Imaging Holdings, Inc. (LMRI) reported Capital Expenditures Incurred but Not yet Paid of $4.82 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-13
- Lumexa Imaging Holdings, Inc. capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was -$6.86M.
- Lumexa Imaging Holdings, Inc. capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $6.86M, a 251.07% increase year-over-year.
- Lumexa Imaging Holdings, Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-06-30 was -$1.95M.
- Lumexa Imaging Holdings, Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-03-31 was $1.95M.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month |
|---|---|---|
| 2026-06-30 | -$6.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $4.82K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $6.86M 10-Q · filed 2026-05-12 | |
| 2025-06-30 | -$1.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $3.96K 10-Q · filed 2026-08-13 |
| 2025-03-31 | $1.95M 10-Q · filed 2026-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B |